Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

PRP injections can help increase hair density and thickness in men with hair loss.

Combining minoxidil with microneedling or spironolactone is more effective for female hair loss than using minoxidil alone.

Certain metabolites can either protect against or increase the risk of hair loss.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Latisse (bimatoprost 0.03%) is widely used in dermatology but the document doesn't give detailed evidence or numbers.

Helmet-like device safely increases hair density for people with hair loss.

PRP generally shows better results for hair regrowth than mesotherapy, but more research is needed.

Oral Apremilast effectively treats alopecia areata in most patients.

Finasteride effectively treats baldness but may cause sexual side effects.

Stem cell treatments show promise for hair loss but need more research.

Adding the topical gel improved hair growth more than using minoxidil or finasteride alone.

Finasteride can cause sexual problems and depression in young men.

PRP and cell therapies may help with hair loss, but more research is needed.

Certain spices may help prevent and treat skin cancer, but more human trials are needed.

Methotrexate is not proven to maintain remission in ulcerative colitis.

The 2003 guidelines suggest that while some treatments can regrow hair in alopecia areata, none alter the disease's progression, and wigs may be the best option for extensive hair loss.

There is no gold standard treatment for hidradenitis suppurativa due to insufficient evidence.

Gilles de la Tourette syndrome is treatable, with behavioral therapy as a recommended first option and other treatments available for more severe cases.

Home-use cosmetic laser and light devices show modest results for hair removal and acne treatment, but more research is needed for confirmation.

There is no standardized treatment for hidradenitis suppurativa, and individualized plans are needed.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Fat tissue stem cells show promise for repairing different body tissues and are being tested in clinical trials.

Topical therapies show promise for hair loss and acne treatment with minimal side effects.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.